Challenges in TB control and the anticipated COVID-19 third wave: Way forward.

Padmapriyadarsini, C; Banurekha, V; Arora, V K

Padmapriyadarsini, C; Banurekha, V; Arora, V K.

Padmapriyadarsini C; ICMR-National Institute for Research in Tuberculosis, Chetput, Chennai, India. Electronic address: padmapriyadarsinic@nirt.res.in.
Banurekha V; ICMR-National Institute for Research in Tuberculosis, Chetput, Chennai, India.
Arora VK; Tuberculosis Association of India, India.

Indian J Tuberc ; 68(4): 425-427, 2021 10.

Article in English | MEDLINE | ID: covidwho-1330888

Subject(s)

Antitubercular Agents/therapeutic use; COVID-19/epidemiology; Tuberculosis/prevention & control; Disease Eradication; Disease Management; Humans; India/epidemiology; Medication Adherence; Missed Diagnosis; SARS-CoV-2; Tuberculosis/diagnosis; Tuberculosis/epidemiology; Tuberculosis/therapy

Keywords

Covid-19; Lockdown; Pulmonary TB

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / COVID-19 / Antitubercular Agents Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Indian J Tuberc Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google